CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, an innovative biotechnology company focusing on research and production of wellness compounds, announced the closing of the first round of equity funding for its research projects. The company raised $7.5 M to establish world-class research facilities in the Southern California region and assemble an impressive scientific team. “We are excited to announce this milestone,” said Sher Ali Butt, CEO and co-founder of CB Therapeutics. “With the establishm

Click to view original post

Advertise With Us